Literature DB >> 3259202

Recognition of several idiotopes on a monoclonal anti-hepatitis B virus surface antigen using monoclonal anti-idiotypic antibodies.

Y M Thanavala1, M J Moore, R Tedder, F C Hay, I M Roitt.   

Abstract

A monoclonal murine antibody H3F5 directed to the a determinant of hepatitis B surface antigen (HBsAg) was used to raise several monoclonal anti-idiotypes. Cross-blocking experiments between the anti-idiotypes and the patterns of inhibition produced by a number of other monoclonal anti-HBsAg, generated in the same fusion as H3F5, identified three idiotopes on H3F5 which were shared to varying degrees with the other anti-HBsAg monoclonals. One behaved as a dominant cross-reacting idiotope (CRI) in that it appeared strongly in 5/7 monoclonal idiotypes. The CRI could represent an important target for regulation by anti-idiotope. Monoclonal antibodies have many advantages over polyclonal sera in the detailed analysis of idiotope structures.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259202      PMCID: PMC1454800     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  4 in total

1.  Monoclonal 'internal image' anti-idiotypic antibodies of hepatitis B surface antigen.

Authors:  Y M Thanavala; A Bond; R Tedder; F C Hay; I M Roitt
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

2.  Mouse myeloma--spleen cell hybrids: Enhanced hybridization frequencies and rapid screening procedures.

Authors:  L Claflin; K Williams
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

3.  Production of monoclonal antibodies to hepatitis B surface and core antigens, and use in the detection of viral antigens in liver biopsies.

Authors:  R S Tedder; P Guarascio; J L Yao; R B Lord; A L Eddleston
Journal:  J Hyg (Lond)       Date:  1983-02

4.  Enhancement of the immune response to hepatitis B surface antigen. In vivo administration of antiidiotype induces anti-HBs that expresses a similar idiotype.

Authors:  R C Kennedy; G R Dreesman
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.